山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00719 山东新华制药股份

休市中 05-22 16:08:22

6.250

+0.020

+0.32%

最高6.250	最低6.200	成交量33.20万
今开6.200	昨收6.230	日振幅0.80%
总市值43.56亿	流通市值12.19亿	总股本6.97亿
成交额206.80万	换手率0.17%	流通股本1.95亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":6.25,"timestamp":1779437302002,"preClose":6.23,"halted":0,"volume":332000,"delay":0,"changeRate":0.003210272873194153,"floatShares":195000000,"shares":697000000,"eps":0.4840766657002484,"marketStatus":"休市中","change":0.02,"latestTime":"05-22 16:08:22","open":6.2,"high":6.25,"low":6.2,"amount":2067960,"amplitude":0.008026,"askPrice":6.25,"askSize":2000,"bidPrice":6.22,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":0.4448307263103456,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":7,"adr":0,"listingDate":851961600000,"exchange":"SEHK","adjPreClose":6.23,"dividendRate":0.043701,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":0.5156881018709683,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.05,"timestamp":1779433200000,"preClose":14.09,"halted":0,"volume":3192700,"delay":0,"premium":"-61.40"}},"requestUrl":"/m/hq/s/00719","defaultTab":"news","newsList":[{"id":"2636025411","title":"山东新华制药股份(00719)：苯巴比妥片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2636025411","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636025411?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:41","pubTimestamp":1779093698,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，公司收到国家药品监督管理局核准签发的苯巴比妥片《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。2025年5月，新华制药向国家药品监督管理局药品审评中心递交苯巴比妥片一致性评价申报资料并获受理，2026年5月获得《药品补充申请批准通知书》，审评结论为：经审查，本品通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02171","81024","00719","09688","01548","01951","06186","02276","01905","01952","06049","06060","00013","00772","02126","06660","06609","09626","09888","03700","01833","09699","01357","02192","00762","01024","06969","02306","06160","06996","00169","01440","02618","02096","01783","02256","06963","09992","01060","02285","02013","00136","00909","02158","02197","02252","03692","02172","09858","03888"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409903","title":"山东新华制药股份(00719)获得氨溴特罗口服溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409903?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:36","pubTimestamp":1778488577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，公司收到国家药品监督管理局核准签发的氨溴特罗口服溶液《药品注册证书》。2024年5月，新华制药向国家药品监督管理局药品审评中心(CDE)递交氨溴特罗口服溶液上市许可申报资料并获受理，2026年5月获得《药品注册证书》，审评结论为：批准注册。本品用于治疗急、慢性呼吸道疾病(如急、慢性支气管炎、肺气肿等)引起的咳嗽、痰液黏稠、排痰困难、喘息等。根据相关统计数据，2024年中国公立医疗机构氨溴特罗口服溶液销售额约为人民币7.4亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634474014","title":"港股异动 | 山东新华制药股份(00719)午后涨超7% 自主研发的盐酸苄丝肼原料药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2634474014","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634474014?lang=zh_cn&edition=full","pubTime":"2026-05-11 13:37","pubTimestamp":1778477829,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，山东新华制药股份午后涨超7%，截至发稿，涨6.76%，报6.63港元，成交额2313.17万港元。消息面上，据新华制药公众号消息，近日，新华制药自主研发的盐酸苄丝肼原料药正式收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》，获准上市生产。这是新华制药在神经系统疾病治疗领域的又一重要成果，标志着公司在帕金森病全链条药物供应体系上实现新突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4588","BK1515","BK4585","IPOS","00719","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633435907","title":"山东新华制药股份(00719)：盐酸苄丝肼获得化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435907","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633435907?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:34","pubTimestamp":1778229280,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的盐酸苄丝肼《化学原料药上市申请批准通知书》。2024年9月，新华制药向国家药品监督管理局CDE递交盐酸苄丝肼境内生产化学原料药上市申请注册申报资料并获受理， 2026年5月获得《化学原料药上市申请批准通知书》，审评结论为批准生产本品。根据相关统计数据，2025年中国公立医疗机构多巴丝肼相关制剂销售额约为人民币14亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","00719","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186411373","title":"山东新华制药股份更新2026年4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1186411373","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186411373?lang=zh_cn&edition=full","pubTime":"2026-05-06 08:11","pubTimestamp":1778026278,"startTime":"0","endTime":"0","summary":"山东新华制药股份于2026年5月6日公布截至2026年4月30日的股份变动月报表。报告期内，公司已发行股份总数保持不变，未发生新增发行、回购或注销等变化。在股权激励方面，公司2021年A股股票期权计划的期权数量维持为1,155,000份，未有新增授出、行使或失效记录。公司同时表示，2026年4月期间未发生回购或库藏股相关活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8d4c202617d87be1d9fe31f833a300a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632604150","title":"格隆汇个股放量排行榜 | 5月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632604150","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632604150?lang=zh_cn&edition=full","pubTime":"2026-05-03 17:30","pubTimestamp":1777800604,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日天数智芯(09903)、上海实业控股(00363)、网易-S(09999)、永达汽车(03669)、永利澳门(01128)、中国铁建(01186)、中国信达(01359)、力量发展(01277)、中国光大银行(06818)、汽车街(02443)、中国白银集团(00815)、赛力斯(09927)、太古股份公司A(00019)、中信国际电讯(01883)、华星控股(08","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/03173056983654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00568","00178","02489","00259","00019","02516","00815","02687","00501","00650","00719","06979","09903","01211","01833","02676","01643","06938","01765","02637","02583","00800","06821","00880","00659","01458","00709","00981","02443","02579","09927","00909","02655","02656","02408","00189","02595","00780","00133","01347","00148","09990","00220","00558","00168","06110","01429","00363","02276","09999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632158966","title":"格隆汇个股放量排行榜 | 5月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632158966","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632158966?lang=zh_cn&edition=full","pubTime":"2026-05-01 17:30","pubTimestamp":1777627804,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日天数智芯(09903)、上海实业控股(00363)、网易-S(09999)、永达汽车(03669)、永利澳门(01128)、中国铁建(01186)、中国信达(01359)、力量发展(01277)、中国光大银行(06818)、汽车街(02443)、中国白银集团(00815)、赛力斯(09927)、太古股份公司A(00019)、中信国际电讯(01883)、华星控股(08","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/01173056970876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00909","00019","00259","00650","01765","01211","01643","02516","06979","01833","00880","00981","02579","02583","00815","02687","09927","06110","00363","00709","00780","02489","00133","00800","09903","09990","02595","02408","01347","09999","00558","02276","00568","06821","00719","00189","02676","00148","01429","02655","02637","00501","06938","00168","02443","01458","00178","02656","00220","00659"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1169278373","title":"山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169278373","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169278373?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:42","pubTimestamp":1777369369,"startTime":"0","endTime":"0","summary":"山东新华制药股份在2025年度实现营业收入87.55亿元人民币，同比上升3.41%；归属于上市公司股东的净利润为2.89亿元，同比下降38.32%，扣除非经常性损益后净利润2.88亿元，降幅为40.10%。基本每股收益0.42元，同比减少39.13%。报告期内经营活动产生的现金流量净额为5.34亿元，同比增长45.19%。分业务板块来看，化学原料药贡献收入26.46亿元，占比约30.22%，制剂业务39.86亿元，占比45.52%，医药中间体及其他约21.24亿元，占比24.26%，形成多元化的营收结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195573397","title":"山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195573397","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195573397?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:41","pubTimestamp":1777369287,"startTime":"0","endTime":"0","summary":"本季度信息\n2026年第一季度，山东新华制药股份实现营收24.23亿元，同比下降0.28%。经调整净利润（归属于上市公司股东并扣除非经常性损益后）为0.80亿元，同比下降23.55%。本期经营活动产生的现金流量净额为-1.17亿元，相比去年同期的0.08亿元大幅减少，主要受到营运资金占用等影响。\n从成本结构看，销售费用约1.03亿元，同比微增3.53%；管理费用约0.95亿元，同比上涨0.92%；研发费用约0.95亿元，同比减少13.07%。整体财务指标显示出成本端仍在波动，研发投入维持在较高水平。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630741043","title":"山东新华制药股份(00719)一季度归母净利润8390.3万元，同比下降25.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630741043","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630741043?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:39","pubTimestamp":1777369170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，2026年第一季度，营业收入24.23亿元，同比下降0.28%;归属于上市公司股东的净利润8390.3万元，同比下降25.15%;基本每股收益0.12元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629735816","title":"山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2629735816","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629735816?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:35","pubTimestamp":1777019735,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的氯化钾颗粒《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。2026年3月，新华制药向国家药品监督管理局递交上市许可持有人变更的补充申请资料并获得受理，2026年4月获得药品补充申请批准通知书，审评结论为：本品持有人转让申请符合药品上市后变更管理的有关要求，批准本品上市许可持有人变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772986","title":"智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629772986?lang=zh_cn&edition=full","pubTime":"2026-04-21 07:28","pubTimestamp":1776727718,"startTime":"0","endTime":"0","summary":"根据2026年4月20日询价申购情况，初步确定的本次询价转让价格为410.34元/股。本次询价转让不通过集中竞价交易方式或大宗交易方式进行，不属于通过二级市场减持。受让方通过询价转让受让的股份，在受让后6个月内不得转让。截至收盘，暗盘交易显示报价333港元，较招股价209.88港元上涨58.66%，每手100股，不计手续费，每手赚12312港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bd99c7d8869305150ea2122170bfd90e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1580142542.USD","LU2097828474.EUR","LU2294711713.HKD","603093","LU0328353924.USD","LU0505663152.USD","SGXZ81163826.USD","LU2148510915.USD","LU2424517915.HKD","LU0516422366.SGD","LU0593848301.USD","LU0039217434.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU0149534421.HKD","LU1152091168.USD","BK1129","LU1226287875.USD","LU2298321311.HKD","LU0107464264.USD","LU2348773727.SGD","LU0605514214.HKD","LU0124384867.USD","BK1521","03393","LU0405327148.USD","LU1328277881.USD","LU1808992512.USD","LU2092937221.SGD","BK1147","IE00BZ08YT58.USD","LU1997245094.SGD","LU2097828714.EUR","LU0501845795.SGD","02691","SG9999002828.SGD","LU1861219969.SGD","LU1960683339.HKD","300750","LU1064131003.USD","LU2348774022.SGD","LU2476274308.USD","LU0192582467.USD","LU0235996351.USD","LU0048575426.USD","LU0011963245.USD","LU0259732245.USD","LU1721428347.USD","LU2125910849.SGD","002466","LU0054450605.USD","LU2506951792.HKD","01093","LU0140636845.USD","LU1993786604.SGD","LU0210526637.USD","BK4585","IE00B8HQ1Z84.USD","LU2125910500.SGD","LU1807302812.USD","LU2506952253.HKD","LU2275660780.HKD","LU2360107325.USD","LU0611395673.USD","LU2289578879.USD","LU0326950275.SGD","LU0456827905.SGD","LU0650527681.SGD","LU2580892789.USD","LU2298322129.HKD","SG9999003461.SGD","LU1978683503.SGD","LU1152091754.HKD","LU0029875118.USD","LU2045819591.USD","LU0188438112.USD","LU2039709279.SGD","LU0072913022.USD","LU0315179316.USD","EVS.SI","LU1820825898.SGD","LU1188198961.HKD","LU2495084118.USD","SG9999001689.USD","SG9999000327.SGD","SNFRY","LU1242518857.USD","SG9999000459.SGD","BK1610","LU0164865239.USD","LU1039395188.USD","LU2097828631.EUR","LU0672654166.SGD","BK1554","LU0359201885.HKD","LU0128522157.USD","IE00BPRC5H50.USD","LU0043850808.USD","LU2238339852.HKD","LU0067412154.USD","LU0651946864.USD","LU2476274720.SGD","LU0048388663.USD","LU1655091616.SGD","LU0469268626.HKD","LU0607220059.USD","LU0143863784.USD","LU0516423174.USD","06608","BK1594","LU1969619763.USD","IE00BZ199S13.USD","600941","LU0724618433.USD","LU1770034418.SGD","LU1831875114.USD","LU2778985437.USD","LU1979443071.USD","09696","TSLA","LU1813983027.USD","HK0000181112.HKD","LU0405327494.USD","LU1781817850.SGD","IE00B3M56506.USD","LU0327786744.USD","SG9999014674.SGD","LU0828237940.HKD","LU1951186391.HKD","LU1051768304.USD","LU2097828557.USD","LU0531970944.HKD","LU0370786039.SGD","LU0828237510.HKD","SG9999002463.SGD","LU1251922891.USD","LU1051769294.HKD","LU1961090484.USD","LU0231483743.USD","LU0348805143.USD","LU1769817096.USD","IE0032431581.USD","IE0008369823.USD","LU0072462343.USD","BK1116","LU2152927971.USD","LU0165289439.USD","LU2449936058.SGD","LU1102505762.USD","LU1868837565.USD","300476","LU0543330483.HKD","00451","LU0312595415.SGD","LU0516422440.USD","LU0049853897.USD","LU0531971595.HKD","LU0572944931.SGD","LU2153591404.USD","LU1868838027.USD","BK4141","LU2298064838.USD","LU1064130708.USD","LU1939255532.USD","BK1154","601607","LU0823414478.USD","LU1023057109.AUD","BK4526","LU2249611893.SGD","LU1303224171.USD","LU1515016050.SGD","LU0048580855.USD","LU2041044095.USD","LU2328871848.SGD","LU0244354667.USD","LU0320764755.SGD","LU0502904849.HKD","SG9999004220.SGD","SG9999001846.SGD","LU1880383440.USD","BK1191","LU0880133367.SGD","LU0823426480.USD","LU0214875030.USD","LU1146622755.USD","LU0455707207.USD","LU1861214812.USD","LU0314109678.HKD","LU2506952337.HKD","LU0594300419.USD","LU1242518931.SGD","IE0003851619.USD","SHPMY","HK0000181138.USD","LU1102505929.USD","LU1934453819.USD","IE00B5MMRT66.SGD","LU0228659784.USD","LU2097828805.USD","LU2360108059.USD","IE00B543WZ88.USD","02476","LU0106259558.USD","IE0003795394.USD","LU0143863198.USD","LU0106959298.USD","LU0828238088.HKD","LU1997244956.HKD","IE00B031HY20.USD","BK0224","LU2357125470.USD","PLUG","IE00BZ08YS42.EUR","LU2477742899.HKD","LU2242644610.SGD","LU0164872284.USD","LU0516423091.SGD","LU1048588211.SGD","LU0449515922.USD","HK0000165453.HKD","LU1720050803.USD","03200","03983","02607","04335","LU0302445910.USD","00719","CBLUY","LU0463099449.HKD","LU0509642566.USD","LU1226288253.USD","LU1719994722.HKD","LU0594300179.USD","LU2394011477.USD","LU0823437842.USD","IE00B8L5B284.USD","LU0979878070.USD","BK4588","LU2153592121.USD","LU1048596156.SGD","LU0132412106.USD","LU1226287529.USD","LU2399975544.HKD","LU0047713382.USD","LU0359201612.USD","01866","00941","BK4519","LU0106252389.USD","LU0251143458.SGD","LU0254981946.USD","LU0651947912.USD","COIN","LU0823414551.USD","LU1769817179.HKD","SG9999001903.USD","00297","LU3063872942.SGD","LU1880383366.USD","LU0269904917.USD","IE0008368742.USD","03750","301200","LU0449509016.USD","LU0051755006.USD","02575","IE00B29SXG58.USD","LU0326948709.USD","LU2506952410.USD","LU1794554557.SGD","LU1255011170.USD","IE00BD6J9T35.USD","LU2580892862.HKD","LU0871576103.HKD","LU0823426308.USD","LU0181495838.USD","BK1515","LU0261950470.USD","LU0516422952.EUR","META","LU2294711473.HKD","000756","LU1997245177.USD","SGXZ49509284.SGD","INTC","LU0821914370.USD","LU0359202008.SGD","LU1226288170.HKD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627402897","title":"山东新华制药股份(00719)获得布美他尼注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627402897","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627402897?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:34","pubTimestamp":1776242083,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的布美他尼注射液《药品注册证书》。2026年4月，新华制药获得布美他尼注射液《药品注册证书》，审评结论为批准注册。布美他尼注射液属于《国家基本医疗保险、工伤保险和生育保险药品目录》乙类品种。根据相关统计数据，2024年中国公立医疗机构布美他尼注射液销售额约为人民币4.7亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得布美他尼注射液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625193227","title":"山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2625193227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625193227?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:17","pubTimestamp":1775560662,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的钠钾镁钙注射用浓溶液《药品注册证书》。2024年6月，北京民康百草医药科技有限公司向国家药品监督管理局药品审评中心递交了钠钾镁钙注射用浓溶液上市许可注册申报资料并获受理。新华制药的钠钾镁钙注射用浓溶液于2026年4月取得药品注册证书，有利于丰富公司制剂产品系列，提高竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624579462","title":"市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表","url":"https://stock-news.laohu8.com/highlight/detail?id=2624579462","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624579462?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:06","pubTimestamp":1775117205,"startTime":"0","endTime":"0","summary":"相信光的力量？","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3769090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","TCEHY","BK4588","COHR","BIDU","01879","BK4585","BK4535","LITE","09888","000756","00700"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624359514","title":"山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624359514","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624359514?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:38","pubTimestamp":1775032680,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，公司收到国家药品监督管理局核准签发的人工牛黄甲硝唑胶囊《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。2026年3月，新华制药向国家药品监督管理局递交上市许可持有人变更的补充申请资料并获得受理，近日获得药品补充申请批准通知书，审评结论为：本品持有人转让申请符合药品上市后变更管理的有关要求，批准本品上市许可持有人变更。本品适用于急性智齿冠周炎，局部牙槽脓肿、牙髓炎、根尖周炎等。根据相关统计数据，2024年中国公立医疗机构人工牛黄甲硝唑胶囊销售额约为人民币5.79亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","00719","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147752343","title":"山东新华制药股份2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1147752343","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147752343?lang=zh_cn&edition=full","pubTime":"2026-04-01 08:26","pubTimestamp":1775003183,"startTime":"0","endTime":"0","summary":"山东新华制药股份有限公司于2026年4月1日发布2026年3月股份变动月报表。公告显示，截至2026年3月31日，公司总股本继续保持稳定，未发生新增发行、购回或注销等活动。\n报告期内，H股已发行数量为195,000,000股，A股已发行数量为501,683,435股，两者均与上月末持平，合计注册股本为696,683,435股。公司在期权与激励计划方面无行权或失效事项，1,155,000股期权全部维持至报告期末。\n公告同时确认遵守香港联交所《上市规则》及相关法规，所有已发行股份合规合法，无任何库存股份变动。该公告由公司秘书曹长求签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304499","title":"山东新华制药股份(00719)：徐列辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304499","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623304499?lang=zh_cn&edition=full","pubTime":"2026-03-31 16:50","pubTimestamp":1774947033,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，公司非执行董事徐列先生因达退休年龄辞任公司董事以及董事会发展战略委员会成员职务。该辞任自2026年3月31日起生效，之后徐先生在公司已无担任任何职位及职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622415898","title":"山东新华制药股份(00719)发布年度业绩 归母净利润2.9亿元 同比减少38.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622415898","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622415898?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:50","pubTimestamp":1774601434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布截至2025年12月31日止年度业绩，营业收入87.55亿元，同比增加3.41%;归母净利润2.9亿元，同比减少38.32%;基本每股收益0.42元;拟派发末期股息每股0.15元。公告称，全年取得药品批件47个，创历史新高。充分发挥塬料药综合优势，国内销售收入保持稳定增长，布洛芬、卡巴匹林钙等重点产品国内市占率进一步扩大。特色塬料药美洛昔康、格列美脲、碳酸司维拉姆出口销量同比大幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xhzy.com","stockEarnings":[{"period":"1week","weight":-0.0048},{"period":"1month","weight":-0.0142},{"period":"3month","weight":-0.1147},{"period":"6month","weight":-0.0672},{"period":"1year","weight":0.104},{"period":"ytd","weight":-0.0516}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0153},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东新华制药股份有限公司是一家主要从事化学原料药、制剂及化工产品的开发、制造和销售的中国公司。该公司运营三个分部。化学原料药分部主要从事咖啡因系列、布洛芬系列、阿司匹林系列、多巴系列、巴比妥系列及吡哌酸等解热镇痛类原料药的开发、制造及销售。制剂分部主要从事吡哌酸片、安痛定及尼莫地平片等片剂、针剂及胶囊剂等制剂的开发、制造及销售。医药中间体及其他产品分部主要从事医药中间体及其他产品的开发、制造及销售。该公司主要在中国国内市场及美洲和欧洲等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.012276},{"month":2,"riseRate":0.766667,"avgChangeRate":0.099858},{"month":3,"riseRate":0.433333,"avgChangeRate":-0.00788},{"month":4,"riseRate":0.7,"avgChangeRate":0.100968},{"month":5,"riseRate":0.366667,"avgChangeRate":0.000323},{"month":6,"riseRate":0.448276,"avgChangeRate":-0.003358},{"month":7,"riseRate":0.586207,"avgChangeRate":0.015918},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.041915},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.018334},{"month":10,"riseRate":0.448276,"avgChangeRate":0.008832},{"month":11,"riseRate":0.551724,"avgChangeRate":0.012328},{"month":12,"riseRate":0.586207,"avgChangeRate":0.023867}],"exchange":"SEHK","name":"山东新华制药股份","nameEN":"SHANDONG XINHUA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山东新华制药股份,00719,山东新华制药股份股票,山东新华制药股份股票老虎,山东新华制药股份股票老虎国际,山东新华制药股份行情,山东新华制药股份股票行情,山东新华制药股份股价,山东新华制药股份股市,山东新华制药股份股票价格,山东新华制药股份股票交易,山东新华制药股份股票购买,山东新华制药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}